NO20054225D0 - Benzamid-derivater som oksytocin-agonister og vasopressin-antagonister - Google Patents
Benzamid-derivater som oksytocin-agonister og vasopressin-antagonisterInfo
- Publication number
- NO20054225D0 NO20054225D0 NO20054225A NO20054225A NO20054225D0 NO 20054225 D0 NO20054225 D0 NO 20054225D0 NO 20054225 A NO20054225 A NO 20054225A NO 20054225 A NO20054225 A NO 20054225A NO 20054225 D0 NO20054225 D0 NO 20054225D0
- Authority
- NO
- Norway
- Prior art keywords
- benzamide derivatives
- vasopressin antagonists
- oxytocin agonists
- oxytocin
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03003394A EP1449844A1 (en) | 2003-02-14 | 2003-02-14 | benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| PCT/EP2004/001304 WO2004072083A1 (en) | 2003-02-14 | 2004-02-12 | Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054225D0 true NO20054225D0 (no) | 2005-09-12 |
| NO20054225L NO20054225L (no) | 2005-11-14 |
Family
ID=32731527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054225A NO20054225L (no) | 2003-02-14 | 2005-09-12 | Benzamid-derivater som oksytocin-agonister og vasopressin-antagonister |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7407949B2 (no) |
| EP (2) | EP1449844A1 (no) |
| JP (1) | JP2006517530A (no) |
| KR (1) | KR100725560B1 (no) |
| CN (1) | CN100349896C (no) |
| AU (1) | AU2004212140B2 (no) |
| CA (1) | CA2513220A1 (no) |
| MX (1) | MXPA05008601A (no) |
| NO (1) | NO20054225L (no) |
| NZ (1) | NZ540768A (no) |
| PL (1) | PL379702A1 (no) |
| RU (1) | RU2340617C2 (no) |
| WO (1) | WO2004072083A1 (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000079D0 (en) | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| EP1632494A1 (en) * | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
| RU2008114374A (ru) * | 2005-10-24 | 2009-12-10 | Вайет (Us) | Трициклические соединения, применяемые в качестве агонистов рецептора окситоцина |
| GB0903493D0 (en) | 2009-02-27 | 2009-04-08 | Vantia Ltd | New compounds |
| JP5546636B2 (ja) * | 2009-09-28 | 2014-07-09 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ベンゾキセピンｐｉ３ｋ阻害剤化合物及び使用方法 |
| GB201004677D0 (en) | 2010-03-19 | 2010-05-05 | Vantia Ltd | New salt |
| CA2799733A1 (en) | 2010-05-18 | 2011-11-24 | Universite De Geneve | New uses of oxytocin-like molecules and related methods |
| ES2595251T3 (es) | 2010-05-25 | 2016-12-28 | Inserm - Institut National De La Santé Et De La Recherche Médicale | Métodos y composición farmacéutica para el tratamiento de un trastorno alimentario con inicio temprano en un paciente |
| MX2019006942A (es) * | 2016-12-12 | 2019-10-21 | Univ Sydney | Agonistas de receptores de oxitocina no peptidicos. |
| US11033601B2 (en) | 2017-09-14 | 2021-06-15 | The Regents Of The University Of Colorado, A Body Corporate | Selective inhibition of V1b for treating fatty liver |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5760031A (en) * | 1993-07-29 | 1998-06-02 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US7326700B2 (en) * | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| GB0115515D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Oxytocin agonisys |
| GB0120051D0 (en) * | 2001-08-16 | 2001-10-10 | Ferring Bv | Oxytocin agonists |
-
2003
- 2003-02-14 EP EP03003394A patent/EP1449844A1/en not_active Withdrawn
-
2004
- 2004-02-12 JP JP2006500029A patent/JP2006517530A/ja not_active Withdrawn
- 2004-02-12 EP EP04710384A patent/EP1592693A1/en not_active Withdrawn
- 2004-02-12 MX MXPA05008601A patent/MXPA05008601A/es active IP Right Grant
- 2004-02-12 RU RU2005122323/04A patent/RU2340617C2/ru not_active IP Right Cessation
- 2004-02-12 CN CNB2004800042329A patent/CN100349896C/zh not_active Expired - Fee Related
- 2004-02-12 KR KR1020057014970A patent/KR100725560B1/ko not_active IP Right Cessation
- 2004-02-12 NZ NZ540768A patent/NZ540768A/en unknown
- 2004-02-12 US US10/541,460 patent/US7407949B2/en not_active Expired - Fee Related
- 2004-02-12 WO PCT/EP2004/001304 patent/WO2004072083A1/en active Application Filing
- 2004-02-12 PL PL379702A patent/PL379702A1/pl not_active Application Discontinuation
- 2004-02-12 CA CA002513220A patent/CA2513220A1/en not_active Abandoned
- 2004-02-12 AU AU2004212140A patent/AU2004212140B2/en not_active Ceased
-
2005
- 2005-09-12 NO NO20054225A patent/NO20054225L/no not_active Application Discontinuation
-
2008
- 2008-06-20 US US12/213,576 patent/US20080275026A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004212140A1 (en) | 2004-08-26 |
| CA2513220A1 (en) | 2004-08-26 |
| AU2004212140B2 (en) | 2006-12-21 |
| RU2005122323A (ru) | 2006-02-27 |
| RU2340617C2 (ru) | 2008-12-10 |
| CN1751050A (zh) | 2006-03-22 |
| CN100349896C (zh) | 2007-11-21 |
| NZ540768A (en) | 2008-05-30 |
| US20080275026A1 (en) | 2008-11-06 |
| EP1592693A1 (en) | 2005-11-09 |
| KR20050098931A (ko) | 2005-10-12 |
| NO20054225L (no) | 2005-11-14 |
| PL379702A1 (pl) | 2006-11-13 |
| JP2006517530A (ja) | 2006-07-27 |
| MXPA05008601A (es) | 2005-11-04 |
| KR100725560B1 (ko) | 2007-06-08 |
| WO2004072083A1 (en) | 2004-08-26 |
| US7407949B2 (en) | 2008-08-05 |
| US20060166971A1 (en) | 2006-07-27 |
| EP1449844A1 (en) | 2004-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054225D0 (no) | Benzamid-derivater som oksytocin-agonister og vasopressin-antagonister | |
| NO20040028L (no) | Substituerte anilinske piperidiner som MCH-selektive antagonister | |
| NO20044654L (no) | Piperidinoylpiperidiner som 5-HTIF-agonister | |
| NO20053569D0 (no) | Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som nevrokininantagonister | |
| NO20043997L (no) | 4-(N-fenylamino)-kinazoliner/kinoliner som tyrokinaseinhibitorer | |
| NO20052739D0 (no) | CCR5-antagonister som medikamenter | |
| DK1523493T3 (da) | Nye tubulysinanaloge | |
| DK1997810T3 (da) | Indazoler, benzotriazoler og N-analoger deraf som p38-kinaseinhibitorer | |
| NO20054868D0 (no) | CaSr antagonist | |
| PL394144A1 (pl) | Mieszaniny chwastobójcze zawierające acylowane aminofenylosulfonylomoczniki | |
| DK1484970T3 (da) | Benzamider og sammensætninger omfattende benzamider til anvendelse som fungicider | |
| IS8248A (is) | Útskipt tvíketópíperasín og notkun þeirra sem oxytósínmótlyfja | |
| NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
| DK1667668T3 (da) | Alfabeta3 og altabeta6-integrinantagonister som antifibrotiske midler | |
| NO20040996L (no) | Nye forbindelser og sammensetninger som catepsin-inhibitorer | |
| DK1648882T3 (da) | 3-fluor-piperidiner som NMDA/NR2B-antagonister | |
| NO20041819L (no) | Diazacykloalakaner som oksytocinagonister | |
| DE60325848D1 (de) | Flammwidrige zusammensetzungen | |
| ITTO20030385A1 (it) | Estintore portatile ad aerosol | |
| DE60324018D1 (de) | Agonisten | |
| EP1654232A4 (en) | N- (BIARYLMETHYL) AMINOCYCLOPROPANECARBOXAMIDES WITH SULFONYL SUBSTITUTION | |
| NO20053598D0 (no) | Substituerte 1-piperidin-3-yl-4-pyrrolidin-4-yl-piperazinderivater og deres anvendelse som nevrokininantagonister. | |
| DE60332592D1 (de) | Tragbares Endgerät | |
| DK1485358T3 (da) | Substitueret benzimidazol-sulfonamid som bred-sprektrum HIV-protease-inhibitorer | |
| ITTV20020045A1 (it) | Miscela estinguente |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |